TRANSURETHRAL ENUCLEATION OF THE PROSTATE – A NEW FUNCTIONAL STANDARD IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA TREATMENT

Abstract

Objectives. Lower urinary tract symptoms, caused by benign prostatic hyperplasia, are one of the most common reasons to attend an urologist for older men. Despite the availability of a wide range of conservative methods, these may not always solve the symptoms of benign prostatic hyperplasia and often only delay the surgical treatment. The aim of this study is to analyze the functional effectiveness of transurethral enucleation of the prostate using bipolar energy and Thulium: YAG laser.

Material and methods. From 2020 to 2021, 45 patients with benign prostatic hyperplasia underwent surgical treatment using transurethral methods enucleation of the prostate enucleation: ThuVEP (21 patients) and TUEB (24 patients). All patients were evaluated preoperatively and postoperatively (at 3 and 6 months): IPSS, QoL, TRUS-P with residual urine determination and uroflowmetry. Inclusion criteria were: age ≤80 years; residual urine volume ≥70ml; IPSS ≥20; Qmax ≤ 8,0ml/s.

Results. During the follow-up period, there was a significant improvement at 3 months postoperatively, which continued to progress. There were no significant differences between the research groups (ThuVEP and TUEB) regarding ultrasound modifications and uroflowmetry. A similar reduction of symptomatic scores according to the IPSS and QoL questionnaires was reported by patients.

Conclusions. The widespread use of transurethral enucleation of the prostate can replace classical treatment methods of benign prostatic hyperplasia, demonstrating high functional effectiveness regardless of the preoperative prostate volume.